These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 17106430)

  • 1. Cochlear function in facioscapulohumeral muscular dystrophy.
    Balatsouras DG; Korres S; Manta P; Panousopoulou A; Vassilopoulos D
    Otol Neurotol; 2007 Jan; 28(1):7-10. PubMed ID: 17106430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transient-evoked otoacoustic emissions in a group of professional singers who have normal pure-tone hearing thresholds.
    Hamdan AL; Abouchacra KS; Zeki Al Hazzouri AG; Zaytoun G
    Ear Hear; 2008 Jun; 29(3):360-77. PubMed ID: 18382377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cochlear origin of early hearing loss in vestibular schwannoma.
    Gouveris HT; Victor A; Mann WJ
    Laryngoscope; 2007 Apr; 117(4):680-3. PubMed ID: 17429875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tone-burst and click-evoked otoacoustic emissions in subjects with hearing loss above 0.25, 0.5, and 1 kHz.
    Jedrzejczak WW; Kochanek K; Trzaskowski B; Pilka E; Skarzynski PH; Skarzynski H
    Ear Hear; 2012; 33(6):757-67. PubMed ID: 22710662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in otoacoustic emissions and high-frequency hearing thresholds in children and adolescents.
    Groh D; Pelanova J; Jilek M; Popelar J; Kabelka Z; Syka J
    Hear Res; 2006 Feb; 212(1-2):90-8. PubMed ID: 16364580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extended frequency range hearing thresholds and otoacoustic emissions in acute acoustic trauma.
    Büchler M; Kompis M; Hotz MA
    Otol Neurotol; 2012 Oct; 33(8):1315-22. PubMed ID: 22931865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of cochlear involvement by distortion product otoacoustic emission in Behçet's disease.
    Dagli M; Eryilmaz A; Tanrikulu S; Aydin A; Gonul M; Gul U; Gocer C
    Auris Nasus Larynx; 2008 Sep; 35(3):333-7. PubMed ID: 17996415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Study of the correspondence between pure tone and distorsion product otoacoustic emissions audiometrics: basis for an objective cochlear audiometrics model].
    Jürgens A; Buisan A; Canela M; Abelló P
    Acta Otorrinolaringol Esp; 1999 May; 50(4):253-9. PubMed ID: 10431072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Otoacoustic emissions in patients with hypotension.
    Balatsouras DG; Korres S; Simaskos N; Kandiloros D; Ferekidis E; Economou C
    J Laryngol Otol; 2003 Apr; 117(4):265-9. PubMed ID: 12816214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hearing loss in patients with Behçet's disease: an audiological and transient evoked otoacoustic emission study.
    Aslan S; Serarslan G; Savas N; Teksoz E; Dagli S
    J Laryngol Otol; 2010 Jan; 124(1):10-5. PubMed ID: 19785925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hearing loss in vestibular schwannomas: analysis of cochlear function by means of distortion-product otoacoustic emissions.
    Ferri GG; Modugno GC; Calbucci F; Ceroni AR; Pirodda A
    Auris Nasus Larynx; 2009 Dec; 36(6):644-8. PubMed ID: 19419826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transient evoked otoacoustic emissions and contralateral suppressions in children with auditory listening problems.
    Yalçinkaya F; Yilmaz ST; Muluk NB
    Auris Nasus Larynx; 2010 Feb; 37(1):47-54. PubMed ID: 19411150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of cochlear hearing disorders: normative distortion product otoacoustic emission measurements.
    Mills DM; Feeney MP; Gates GA
    Ear Hear; 2007 Dec; 28(6):778-92. PubMed ID: 17982366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Analysis of evoked otoacoustic emissions in patients with high frequency cochlear hearing loss].
    Ke XM
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 1993; 28(5):268-70, 313. PubMed ID: 8192927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Volterra Slice otoacoustic emissions recorded using maximum length sequences from patients with sensorineural hearing loss.
    de Boer J; Thornton AR
    Hear Res; 2006 Sep; 219(1-2):121-36. PubMed ID: 16887305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distortion product otoacoustic emissions: hit and false-positive rates in normal-hearing and hearing-impaired subjects.
    Musiek FE; Baran JA
    Am J Otol; 1997 Jul; 18(4):454-61. PubMed ID: 9233485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Audiological and transient evoked otoacoustic emission findings in patients with vitiligo.
    Aslan S; Serarslan G; Teksoz E; Dagli S
    Otolaryngol Head Neck Surg; 2010 Mar; 142(3):409-14. PubMed ID: 20172390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term audiometric follow-up of click-evoked auditory brainstem response in hearing-impaired infants.
    Schoonhoven R; Lamoré PJ; de Laat JA; Grote JJ
    Audiology; 2000; 39(3):135-45. PubMed ID: 10905399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inner ear involvement in Behçet's disease.
    Süslü AE; Polat M; Köybaşi S; Biçer YO; Funda YO; Parlak AH
    Auris Nasus Larynx; 2010 Jun; 37(3):286-90. PubMed ID: 19864091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distortion product otoacoustic emission findings in Behçet's disease and rheumatoid arthritis.
    Bayazit YA; Yilmaz M; Gunduz B; Altinyay S; Kemaloglu YK; Onder M; Gurer MA
    ORL J Otorhinolaryngol Relat Spec; 2007; 69(4):233-8. PubMed ID: 17409782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.